[Mechanism of inactivation of cytosine arabinoside in human leukemic leukocytes in relation to clinical effects of the agent].
D003561:Cytarabine / Q000378:metabolism* / Q000627:therapeutic use; D003641:Deamination; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology; D007962:Leukocytes / Q000201:enzymology*
D003561:Cytarabine